Drug intelligence / Profile preview

Sanxiang Ruzengxiao

Development stage
Unknown
Lead developer
Shaanxi Xingbang Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Sanxiang Ruzengxiao is a Traditional Chinese Medicine (TCM) formulation developed by Shaanxi Xingbang Pharmaceutical Co., Ltd., primarily indicated for the treatment of breast hyperplasia (hyperplasia of mammary glands). The formulation is typically administered in capsule form and is composed of several herbal ingredients, including *Cyperus rotundus* (Xiangfu), *Curcuma phaeocaulis* (Ezhu), and *Sparganium stoloniferum* (Sanleng). Based on TCM principles, the drug functions to soothe the liver, regulate qi circulation, activate blood flow, and resolve phlegm to soften hard masses. Clinically, it is used to alleviate breast pain and reduce the size of breast nodules or masses associated with qi stagnation and blood stasis. It is approved for marketing in China under the NMPA registration number 国药准字Z20025071.

Brand names
Sanxiang Ruzengxiao
Other names
Sanxiang Ruzengxiao JiaonangSanxiang Ruzengxiao Capsules

Beyond the preview

Go deeper on Sanxiang Ruzengxiao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanxiang Ruzengxiao.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call